These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

621 related items for PubMed ID: 25803498

  • 1. A Banff Component Scoring-based Histologic Assessment of Bortezomib-based Antibody-mediated Rejection Therapy.
    Sadaka B, Ejaz NS, Shields AR, Cardi MA, Wadih G, Witte D, Abu Jawdeh BG, Alloway RR, Woodle ES.
    Transplantation; 2015 Aug; 99(8):1691-9. PubMed ID: 25803498
    [Abstract] [Full Text] [Related]

  • 2. Clinical and pathological analyses of transplant glomerulopathy cases.
    Shimizu T, Ishida H, Toki D, Nozaki T, Omoto K, Tanabe K, Honda K, Koike J.
    Nephrology (Carlton); 2014 Jun; 19 Suppl 3():21-6. PubMed ID: 24842817
    [Abstract] [Full Text] [Related]

  • 3. Bortezomib for the treatment of chronic antibody-mediated kidney allograft rejection: a case report.
    Schwaiger E, Regele H, Wahrmann M, Werzowa J, Haidbauer B, Schmidt A, Böhmig GA.
    Clin Transpl; 2010 Jun; ():391-6. PubMed ID: 21696056
    [Abstract] [Full Text] [Related]

  • 4. Treatment of acute antibody-mediated rejection using bortezomib: a case report.
    Sin YH, Kim YJ, Oh JS, Lee JH, Kim SM, Kim JK.
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():86-9. PubMed ID: 26031595
    [Abstract] [Full Text] [Related]

  • 5. Late antibody-mediated rejection in renal allografts: outcome after conventional and novel therapies.
    Gupta G, Abu Jawdeh BG, Racusen LC, Bhasin B, Arend LJ, Trollinger B, Kraus E, Rabb H, Zachary AA, Montgomery RA, Alachkar N.
    Transplantation; 2014 Jun 27; 97(12):1240-6. PubMed ID: 24937198
    [Abstract] [Full Text] [Related]

  • 6. Concurrent acute cellular rejection is an independent risk factor for renal allograft failure in patients with C4d-positive antibody-mediated rejection.
    Matignon M, Muthukumar T, Seshan SV, Suthanthiran M, Hartono C.
    Transplantation; 2012 Sep 27; 94(6):603-11. PubMed ID: 22932115
    [Abstract] [Full Text] [Related]

  • 7. Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection.
    Walsh RC, Everly JJ, Brailey P, Rike AH, Arend LJ, Mogilishetty G, Govil A, Roy-Chaudhury P, Alloway RR, Woodle ES.
    Transplantation; 2010 Feb 15; 89(3):277-84. PubMed ID: 20145517
    [Abstract] [Full Text] [Related]

  • 8. Acute Antibody-Mediated Rejection in Kidney Transplant Based on the 2013 Banff Criteria: Single-Center Experience in Uruguay.
    Nin M, Coitiño R, Kurdian M, Orihuela L, Astesiano R, Garau M, López D, Rievas G, Rodriguez I, González-Martínez F, Noboa O.
    Transplant Proc; 2016 Mar 15; 48(2):612-5. PubMed ID: 27110014
    [Abstract] [Full Text] [Related]

  • 9. The clinical and molecular significance of C4d staining patterns in renal allografts.
    Hayde N, Bao Y, Pullman J, Ye B, Calder BR, Chung M, Schwartz D, Alansari A, de Boccardo G, Ling M, Akalin E.
    Transplantation; 2013 Feb 27; 95(4):580-8. PubMed ID: 23274969
    [Abstract] [Full Text] [Related]

  • 10. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification.
    Mauiyyedi S, Crespo M, Collins AB, Schneeberger EE, Pascual MA, Saidman SL, Tolkoff-Rubin NE, Williams WW, Delmonico FL, Cosimi AB, Colvin RB.
    J Am Soc Nephrol; 2002 Mar 27; 13(3):779-787. PubMed ID: 11856785
    [Abstract] [Full Text] [Related]

  • 11. The Relationship of the Severity and Category of Acute Rejection With Intimal Arteritis Defined in Banff Classification to Clinical Outcomes.
    Wu K, Budde K, Schmidt D, Neumayer HH, Rudolph B.
    Transplantation; 2015 Aug 27; 99(8):e105-14. PubMed ID: 25719260
    [Abstract] [Full Text] [Related]

  • 12. Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial.
    Eskandary F, Bond G, Schwaiger E, Kikic Z, Winzer C, Wahrmann M, Marinova L, Haslacher H, Regele H, Oberbauer R, Böhmig GA.
    Trials; 2014 Apr 03; 15():107. PubMed ID: 24708575
    [Abstract] [Full Text] [Related]

  • 13. The significance of C4d staining with minimal histologic abnormalities.
    Haas M.
    Curr Opin Organ Transplant; 2010 Feb 03; 15(1):21-7. PubMed ID: 19907328
    [Abstract] [Full Text] [Related]

  • 14. Acute T cell-mediated rejection accompanied by C4d-negative acute antibody-mediated rejection and cell debris in tubulus: A case report.
    Takamura T, Yamamoto I, Nakada Y, Katsumata H, Yamakawa T, Furuya M, Mafune A, Kobayashi A, Tanno Y, Miki J, Ohkido I, Tsuboi N, Yamamoto H, Yokoo T.
    Nephrology (Carlton); 2015 Jul 03; 20 Suppl 2():70-4. PubMed ID: 26031591
    [Abstract] [Full Text] [Related]

  • 15. Renal allograft biopsies in the era of C4d staining: the need for change in the Banff classification system.
    Al-Aly Z, Reddivari V, Moiz A, Balasubramanian G, Cortese CM, Salinas-Madrigal L, Bastani B.
    Transpl Int; 2008 Mar 03; 21(3):268-75. PubMed ID: 18069927
    [Abstract] [Full Text] [Related]

  • 16. Antibody-mediated rejection and treatment in pediatric patients: one center's experience.
    Gulleroglu K, Baskin E, Bayrakci US, Turan M, Ozdemir BH, Moray G, Karakayali H, Haberal M.
    Exp Clin Transplant; 2013 Oct 03; 11(5):404-7. PubMed ID: 24128133
    [Abstract] [Full Text] [Related]

  • 17. C4D deposition and positive posttransplant crossmatch are not necessarily markers of antibody-mediated rejection in renal allograft recipients.
    Banasik M, Boratyńska M, Nowakowska B, Haloń A, Kościelska-Kasprzak K, Drulis-Fajdasz D, Patrzałek D, Weyde W, Klinger M.
    Transplant Proc; 2007 Nov 03; 39(9):2718-20. PubMed ID: 18021967
    [Abstract] [Full Text] [Related]

  • 18. Probable C4d-negative accelerated acute antibody-mediated rejection due to non-HLA antibodies.
    Niikura T, Yamamoto I, Nakada Y, Kamejima S, Katsumata H, Yamakawa T, Furuya M, Mafune A, Kobayashi A, Tanno Y, Miki J, Yamada H, Ohkido I, Tsuboi N, Yamamoto H, Yokoo T.
    Nephrology (Carlton); 2015 Jul 03; 20 Suppl 2():75-8. PubMed ID: 26031592
    [Abstract] [Full Text] [Related]

  • 19. Indicators of treatment responsiveness to rituximab and plasmapheresis in antibody-mediated rejection after kidney transplantation.
    Immenschuh S, Zilian E, Dämmrich ME, Schwarz A, Gwinner W, Becker JU, Blume CA.
    Transplantation; 2015 Jan 03; 99(1):56-62. PubMed ID: 25121474
    [Abstract] [Full Text] [Related]

  • 20. Pathology of C4d-negative antibody-mediated rejection in renal allografts.
    Haas M.
    Curr Opin Organ Transplant; 2013 Jun 03; 18(3):319-26. PubMed ID: 23283250
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.